Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population‐based study in France
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5645
Abstract: The excess mortality observed in Acute Myeloblastic Leukaemia (AML) patients, partly attributed to unequal access to curative treatments, could be linked to care pathways. read more here.
Keywords: influencing access; acute myeloblastic; factors influencing; myeloblastic leukaemia ... See more keywords
Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia
Sign Up to like & getrecommendations! Published in 2020 at "BMJ Open"
DOI: 10.1136/bmjopen-2019-029642
Abstract: Introduction Acute myeloblastic leukaemia (AML) constitutes the second most common haematological malignancy in the paediatric population. Current treatment regimens are based on the administration of polychemotherapy, combining high doses of cytarabine with anthracyclines and topoisomerase… read more here.
Keywords: consolidation; trial; acute myeloblastic; natural killer ... See more keywords